Trial · NCT02920892
Participant flow27
How many started, completed or left each group, period by period.
1 to 20 of 27
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Placebo Lead-In Period | STARTED | Placebo Lead-In | 110 | |
| Placebo Lead-In Period | STARTED | Double-Blind Placebo, Then Open-Label AFQ056 | 0 | |
| Placebo Lead-In Period | STARTED | Double-Blind AFQ056, Then Open-Label AFQ056 | 0 | |
| Placebo Lead-In Period | COMPLETED | Placebo Lead-In | 99 | |
| Placebo Lead-In Period | COMPLETED | Double-Blind Placebo, Then Open-Label AFQ056 | 0 | |
| Placebo Lead-In Period | COMPLETED | Double-Blind AFQ056, Then Open-Label AFQ056 | 0 | |
| Placebo Lead-In Period | NOT COMPLETED | Placebo Lead-In | 11 | |
| Placebo Lead-In Period | NOT COMPLETED | Double-Blind Placebo, Then Open-Label AFQ056 | 0 | |
| Placebo Lead-In Period | NOT COMPLETED | Double-Blind AFQ056, Then Open-Label AFQ056 | 0 | |
| Placebo-Controlled Period | STARTED | Placebo Lead-In | 0 | |
| Placebo-Controlled Period | STARTED | Double-Blind Placebo, Then Open-Label AFQ056 | 49 | |
| Placebo-Controlled Period | STARTED | Double-Blind AFQ056, Then Open-Label AFQ056 | 50 | |
| Placebo-Controlled Period | COMPLETED | Placebo Lead-In | 0 | |
| Placebo-Controlled Period | COMPLETED | Double-Blind Placebo, Then Open-Label AFQ056 | 46 | |
| Placebo-Controlled Period | COMPLETED | Double-Blind AFQ056, Then Open-Label AFQ056 | 43 | |
| Placebo-Controlled Period | NOT COMPLETED | Placebo Lead-In | 0 | |
| Placebo-Controlled Period | NOT COMPLETED | Double-Blind Placebo, Then Open-Label AFQ056 | 3 | |
| Placebo-Controlled Period | NOT COMPLETED | Double-Blind AFQ056, Then Open-Label AFQ056 | 7 | |
| Open-Label Extension (OLE) Period | STARTED | Placebo Lead-In | 0 | |
| Open-Label Extension (OLE) Period | STARTED | Double-Blind Placebo, Then Open-Label AFQ056 | 46 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02920892/flow